Embed Size (px)
Citation preview
BENELUX CONFERENCENOVEMBER 17TH 2011NEW YORK
VENUE
AGENDA
CONTACT
The Waldorf-Astoria301 Park Avenue, 18th floorNew York, NY 10022
NOVEMBER 17, 2011From 7:30 am Registration8:00 am – 1:00 pm Group Meetings & one–on-ones1:00 pm – 2:00 pm Lunch Break*2:00 pm – 6:00 pm Group Meetings & one–on-ones
* Lunch Buffet will be served between 12:00 pm and 2:00 pm
Sofie Van GijselTel: + 1 212 541 0648E-mail: [email protected]
Benelux Conference New York November 17th 2011
NOVEMBER 16, 2011We cordially invite you to join us for a welcome cocktail at 5:30 pm Co-organized by BelCham (Belgian-American Chamber of Commerce)Hosted by Flanders House and Flanders Investment & Trade
Venue: New York Times Building620 Eighth Avenue, 44th floorNew York, NY 10018
PARTICIPATING COMPANIES
BENELUX CONFERENCE NEW YORK NOVEMBER 17TH 2011
COMPANY FINANCIAL INFORMATION*Mcap as of September 14, 2011 REPRESENTED BY
ChemicalsMcap € 6,222m
www.solvay-investors.com
Patrick Verelst, Head of Investor Relations
Maria Alcon-Hidalgo,Head of Investor Relations Rhodia
BanksMcap € 5,532mwww.kbc.com
Luc Popelier, CFOWim Allegaert, General Manager of
Investor Relations Office
InsuranceMcap € 3,132mwww.ageas.com
Bart De Smet, CEOFrank Vandenborre,
Head of Investor Relations
Industrial EngineeringMcap € 881m
www.arcadis-global.com
Joost Slooten, Director Investor
Relations
Pharmaceuticals & Biotechnology Mcap € 519m
www.thrombogenics.com
Chris Buyse, CFOSteve Pakola, Chief Medical Officer
Technology Hardware & EquipmentMcap € 457m
www.barco.com
Jean-Pierre Tanghe, Senior Vice PresidentCarl Vanden Bussche,
Investor Relations
Equity Investment InstrumentsMcap € 414mwww.rhji.com
Jean-Marc Roelandt, Managing Director
Arnaud Denis, Investor Relations Director
Pharmaceuticals & BiotechnologyMcap € 337m
www.arseus.com
Jan Peeters, CFOConstantijn van Rietschoten, Director Investor Relations
Pharmaceuticals & BiotechnologyMcap € 160mwww.glpg.com
Guillaume Jetten, CFOElizabeth Goodwin,
Director Investor Relations
Pharmaceuticals & BiotechnologyMcap € 68m
www.tigenix.com
Eduardo Bravo, CEOGil Beyen, CBO
Benelux Conference New York November 17th 2011
REGISTRATION FORM (1)
BENELUX CONFERENCE NEW YORK NOVEMBER 17TH 2011
Please return the application form to the attention of:
Sofie Van GijselTel: + 1 212 541 0648
E-mail: [email protected]
PARTICIPANT 1Institution :_____________________________
Mrs - Ms - Mr :__________________________
First Name : ___________________________
Last Name :____________________________
Email :________________________________
Direct phone number :____________________
Mobile :_______________________________
Dietary requirements : ___________________
PARTICIPANT 2Institution :_____________________________
Mrs - Ms - Mr :__________________________
First Name : ___________________________
Last Name :____________________________
Email :________________________________
Direct phone number :____________________
Mobile :_______________________________
Dietary requirements : ___________________
Please fill in your meeting preferences on the following page
Benelux Conference New York November 17th 2011
REGISTRATION FORM (2)
BENELUX CONFERENCE NEW YORK NOVEMBER 17TH 2011
COMPANIESONE-ON-ONE GROUP MEETING
Ageas □ □Arcadis □Arseus □Barco □Galapagos □KBC Group □ □RHJ International □Solvay □ □Thrombogenics □Tigenix □
Benelux Conference New York November 17th 2011
